Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mitoguazone in Refractory/Relapsed AIDS-Related NHL
NCT00002348Phase 2Completed
- Sponsor
- Sanofi
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of mitoguazone in non-Hodgkin lymphoma (NHL), sponsored by Sanofi. Primary endpoint: Objective Response Rate. Status: completed.
02
Drugs
mitoguazone
03
Conditions
non-Hodgkin lymphoma (NHL)
Beyond the preview
Go deeper on NCT00002348.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00002348.